NCT01670942

Brief Summary

The purpose of this research is to see if people who have had a collapsed lung that has been re-expanded can be safely taken to an elevation that a person might experience while in a commercial airplane without having their lung partially collapse again, or have any symptoms such as feeling short of breath or having oxygen levels in the blood decrease while at the simulated altitude. The investigators hypothesize that subjects who have had a collapsed lung that has been re-expanded will not have any adverse symptoms or signs while subjected to a simulated altitude of 8400 feet (565mm Hg) or 12650 ft (471mm Hg).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 23, 2012

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2012

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

April 28, 2014

Status Verified

April 1, 2014

Enrollment Period

1.2 years

First QC Date

August 18, 2012

Last Update Submit

April 25, 2014

Conditions

Keywords

pneumothoraxtraumacommercial air travel

Outcome Measures

Primary Outcomes (1)

  • Change in pneumothorax size

    Will document pneumothorax size before simulated altitude, and size after being at simulated altitude for two hours

    baseline and 2 hours

Study Arms (1)

Traumatic Pneumothorax1

hypobaric chamber

Other: hypobaric chamber

Interventions

We will use a large (26 tons) multi-place hyperbaric and hypobaric chamber at IMC in Murray, Utah (elevation 1500m or 4500ft, average ambient barometric pressure 645mm Hg). In the hypobaric study, the barometric pressure will be lowered to 554mm Hg (phase 1) or 471mm Hg (phase 2) over 20 minutes and held there for two hours.

Traumatic Pneumothorax1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with unilateral pneumothorax of traumatic etiology that has been treated with oxygen, observation, or tube thoracostomy

You may qualify if:

  • Inpatient status on trauma surgery service
  • An established diagnosis of pneumothorax with a traumatic etiology (patients with iatrogenic pneumothorax from attempted central venous line placement will be considered to have a traumatic etiology)
  • Age ≥ 18 at the time of injury

You may not qualify if:

  • Pregnancy
  • Unable to give informed consent
  • Pneumothorax which does not satisfactorily resolve after treatment with tube thoracostomy and requires operative intervention such as video assisted thoracoscopic surgery (VATS) or thoracotomy
  • Pneumothorax requiring tube thoracostomy where the tube has been removed for \< 4 or \> 48 hours
  • Head injury with GCS \< 15 at time of evaluation for study
  • Other injuries or conditions which would preclude participant's ability to remain in chamber for two hours
  • NYHA class III or IV heart failure, active coronary artery disease, arrhythmias, pacemakers, implantable cardiac defibrillator, pulmonary hypertension, claustrophobia
  • Severe obstructive or restrictive lung disease
  • Chronic hypoxemia requiring supplemental oxygen
  • Hypoxemia for any reason (pulmonary contusion, atelectasis, pneumonia, etc.) requiring \> 3 liters supplemental oxygen at the time of entry into the study
  • Inability to tolerate the confines of the chamber

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Intermountain Medical Center

Murray, Utah, 84157, United States

Location

MeSH Terms

Conditions

PneumothoraxWounds and Injuries

Condition Hierarchy (Ancestors)

Pleural DiseasesRespiratory Tract Diseases

Study Officials

  • Sarah Majercik, MD, MBA

    Intermountain Health Care, Inc.

    PRINCIPAL INVESTIGATOR
  • Lindell Weaver, MD

    Intermountain Health Care, Inc.

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MBA, FACS

Study Record Dates

First Submitted

August 18, 2012

First Posted

August 23, 2012

Study Start

October 1, 2012

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

April 28, 2014

Record last verified: 2014-04

Locations